A Randomized, Placebo-Controlled Study of a New Sublingual Formulation of Fentanyl Citrate (Fentanyl Ethypharm) for Breakthrough Pain in Opioid-Treated Patients With Cancer.

A Randomized, Placebo-Controlled Study of a New Sublingual Formulation of Fentanyl Citrate (Fentanyl Ethypharm) for Breakthrough Pain in Opioid-Treated Patients With Cancer. Clin Ther. 2014 Jul 18; Authors: Gombert-Handoko KB PMID: 25048312 [PubMed - as supplied by publisher]

http://www.ncbi.nlm.nih.gov/pubmed/25048312?dopt=Abstract

Source: Clinical Therapeutics - July 18, 2014 Category: Drugs & Pharmacology Authors: Gombert-Handoko KB Tags: Clin Ther Source Type: research